Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.38 USD | -2.53% | -0.95% | -19.11% |
12:07pm | North American Morning Briefing : More Tech -2- | DJ |
Apr. 24 | HSBC Upgrades Gilead Sciences to Hold From Reduce, Price Target is $69 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.11% | 83.65B | |
+24.17% | 562B | |
-6.58% | 358B | |
+19.16% | 322B | |
+7.65% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.34% | 149B | |
-6.94% | 146B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- RBC Raises Price Target on Gilead Sciences to $77 From $76 as FDA Lifts Partial Clinical Hold on Magrolimab; Outperform Kept